Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have received a consensus recommendation of “Hold” from the thirteen research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation, three have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among analysts that have covered the stock in the last year is $33.90.

A number of analysts have recently weighed in on the company. Wells Fargo & Company increased their price objective on Oscar Health from $20.00 to $27.00 and gave the company an “equal weight” rating in a research note on Thursday, August 13th. Robert W. Baird upped their price target on shares of Oscar Health from $27.00 to $33.00 and gave the company a “neutral” rating in a report on Thursday, September 17th. Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. UBS Group raised their price target on shares of Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a report on Friday, August 7th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $48.00 price objective on shares of Oscar Health in a research note on Thursday, September 17th.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $32.38 on Tuesday. The company’s fifty day moving average price is $30.91 and its 200-day moving average price is $25.38. The firm has a market capitalization of $9.99 billion, a price-to-earnings ratio of 23.13, a PEG ratio of 0.34 and a beta of 2.47. Oscar Health has a one year low of $10.69 and a one year high of $34.48. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The company’s revenue for the quarter was up 70.4% on a year-over-year basis. During the same quarter last year, the business posted ($0.89) earnings per share. On average, equities research analysts anticipate that Oscar Health will post 1.83 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In related news, Director Mario Schlosser sold 600,000 shares of the business’s stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $30.34, for a total transaction of $18,204,000.00. Following the transaction, the director owned 480,866 shares in the company, valued at $14,589,474.44. The trade was a 55.51% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Richard Blackley sold 28,869 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $907,930.05. Following the transaction, the chief financial officer directly owned 1,046,108 shares of the company’s stock, valued at $32,900,096.60. The trade was a 2.69% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 874,451 shares of company stock worth $26,761,671 over the last 90 days. 22.64% of the stock is owned by insiders.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. GAMMA Investing LLC boosted its holdings in shares of Oscar Health by 32.9% in the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock valued at $41,000 after purchasing an additional 357 shares during the period. IFP Advisors Inc increased its holdings in Oscar Health by 69.5% during the 2nd quarter. IFP Advisors Inc now owns 2,139 shares of the company’s stock worth $61,000 after purchasing an additional 877 shares during the period. CoreCap Advisors LLC raised its position in Oscar Health by 526.3% during the 2nd quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after purchasing an additional 1,000 shares in the last quarter. Nicholas Wealth LLC. raised its position in Oscar Health by 1.3% during the 1st quarter. Nicholas Wealth LLC. now owns 80,268 shares of the company’s stock valued at $921,000 after purchasing an additional 1,017 shares in the last quarter. Finally, Allworth Financial LP lifted its holdings in shares of Oscar Health by 124.9% in the 2nd quarter. Allworth Financial LP now owns 2,031 shares of the company’s stock worth $58,000 after buying an additional 1,128 shares during the period. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, Inc is a technology-driven health insurance company that provides health plans and related services to individuals, families and businesses in the United States. The company primarily serves members through plans offered under the Affordable Care Act (ACA), including individual and family coverage purchased through government marketplaces.

Oscar’s offerings include medical insurance plans with access to provider networks, prescription drug coverage and member support services.